Lazzaro Spallanzani National Institute for Infectious Diseases
 | You can help expand this article with text translated from the corresponding article in italiano. (January 2023) Click [show] for important translation instructions.
|
The Lazzaro Spallanzani National Institute for Infectious Diseases (Italian: Istituto nazionale per le malattie infettive "L. Spallanzani") is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani.[citation needed] It is the Italian national reference center for Ebola patients.[1] During the COVID-19 pandemic, the Spallanzani Institute was the first research centre in Europe to isolate the genomic sequence of SARS-CoV-2 and upload it to GenBank.[2] The team was composed of Maria Rosaria Capobianchi, Francesca Colavita, and Concetta Castilletti.[3] The institute is working with biotech company ReiThera to test a COVID-19 vaccine candidate called GRAd-COV2, which is based on a modified gorilla adenovirus vector.[4]
References
- ↑ "Nurse in Italy tests positive for Ebola; was in Sierra Leone". U-T San Diego. Retrieved 13 May 2015.
- ↑ "Una speranza dall'Istituto Spallanzani di Roma: "Abbiamo isolato il coronavirus"". La Stampa (in italian). Retrieved 2 February 2020.
{{cite news}}: CS1 maint: unrecognized language (link) - ↑ "Le tre ricercatrici che hanno isolato il Coronavirus allo Spallanzani di Roma". Sky TG24 (in italian). Retrieved 2 February 2020.
{{cite news}}: CS1 maint: unrecognized language (link) - ↑ "New ReiThera vaccine safe, response peak at 4 wks". ANSA. 5 January 2021.
External links
41°51′58″N 12°27′27″E / 41.8662°N 12.4576°E
 | This article about a hospital in Europe is a stub. You can help Wikipedia by expanding it. |
.png){kind=small} | This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
 | This article about an Italian building or structure is a stub. You can help Wikipedia by expanding it. |